{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:34:13Z","timestamp":1789842853008,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,14]]},"DOI":"10.7759\/cureus.78995","type":"journal-article","created":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T13:11:16Z","timestamp":1739538676000},"source":"Crossref","is-referenced-by-count":2,"title":["Methylphenidate-Induced Dyskinesia in a 47-Year-Old Female With Acute Lymphoblastic Leukemia"],"prefix":"10.7759","author":[{"given":"Olivia","family":"Vasey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Francisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo D","family":"Espiridion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","author":"Verghese C","year":"2024","unstructured":"Verghese C, Patel P, Abdijadid S. Methylphenidate. StatPearls Publishing, Treasure Islands, FL; 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK482451\/."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4065\/75.7.711","article-title":"Methylphenidate: its pharmacology and uses","volume":"75","author":"Challman TD","year":"2000","unstructured":"Challman TD, Lipsky JJ. Methylphenidate: its pharmacology and uses. Mayo Clinic Proc. 2000, 75:711-21. 10.4065\/75.7.711","journal-title":"Mayo Clinic Proc"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2013.01.008","article-title":"Acute dyskinetic reaction in a healthy toddler following methylphenidate ingestion","volume":"49","author":"Waugh JL","year":"2013","unstructured":"Waugh JL. Acute dyskinetic reaction in a healthy toddler following methylphenidate ingestion. Pediatr Neurol. 2013, 49:58-60. 10.1016\/j.pediatrneurol.2013.01.008","journal-title":"Pediatr Neurol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.4088\/pcc.v04n0408a","article-title":"A case report of methylphenidate-induced dyskinesia","volume":"4","author":"Heinrich TW","year":"2002","unstructured":"Heinrich TW. A case report of methylphenidate-induced dyskinesia. Prim Care Companion J Clin Psychiatry. 2002, 4:158-9. 10.4088\/pcc.v04n0408a","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14744\/etd.2019.04317","article-title":"Dyskinesia in a prepubertal boy after the first dose of methylphenidate and the association of focal epileptiform activity: a case report","volume":"42","author":"\u00c7evikaslan A","year":"2020","unstructured":"\u00c7evikaslan A, Duman \u00d6, Kutluk M. Dyskinesia in a prepubertal boy after the first dose of methylphenidate and the association of focal epileptiform activity: a case report. Erciyes Med J. 2020, 42:480-2. 10.14744\/etd.2019.04317","journal-title":"Erciyes Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2009.196","article-title":"The clinical approach to movement disorders","volume":"6","author":"Abdo WF","year":"2010","unstructured":"Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010, 6:29-37. 10.1038\/nrneurol.2009.196","journal-title":"Nat Rev Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.4103\/iahs.iahs_71_19","article-title":"Oromandibular dystonia secondary to methylphenidate: a case report and literature review","volume":"7","author":"Rissardo J","year":"2020","unstructured":"Rissardo J, Caprara AF. Oromandibular dystonia secondary to methylphenidate: a case report and literature review. Int Arch Health Sci. 2020, 7:108-11. 10.4103\/iahs.iahs_71_19","journal-title":"Int Arch Health Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/s0887-8994(02)00429-0","article-title":"Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder","volume":"27","author":"Senecky Y","year":"2002","unstructured":"Senecky Y, Lobel D, Diamond GW, et al.. Isolated orofacial dyskinesia: a methylphenidate-induced movement disorder. Pediatric Neurol. 2002, 27:224-6. 10.1016\/s0887-8994(02)00429-0","journal-title":"Pediatric Neurol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/amh.amh_46_18","article-title":"Methylphenidate induced tongue movements","volume":"20","author":"Anand B","year":"2019","unstructured":"Anand B. Methylphenidate induced tongue movements. Arch Mental Health. 2019, 20:26-7. 10.4103\/amh.amh_46_18","journal-title":"Arch Mental Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5455\/bcp.20150902042021","article-title":"Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?","volume":"25","author":"Kazanci SY","year":"2015","unstructured":"Kazanci SY, Tarakcioglu MC, Bulbul L, et al.. Should we continue methylphenidate treatment despite orofacial or extremity dyskinesias?. Psychiatry Clin Psychopharmacol. 2015, 25:399-402. 10.5455\/bcp.20150902042021","journal-title":"Psychiatry Clin Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1177\/0883073812449905","article-title":"Methylphenidate-induced acute orofacial and extremity dyskinesia","volume":"28","author":"Yilmaz AE","year":"2013","unstructured":"Yilmaz AE, Donmez A, Orun E, Tas T, Isik B, Sonmez FM. Methylphenidate-induced acute orofacial and extremity dyskinesia. J Child Neurol. 2013, 28:781-3. 10.1177\/0883073812449905","journal-title":"J Child Neurol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.05.023","article-title":"Methylphenidate as needed for fatigue in patients with advanced cancer. A prospective, double-blind, and placebo-controlled study","volume":"60","author":"Pedersen L","year":"2020","unstructured":"Pedersen L, Lund L, Petersen MA, Sjogren P, Groenvold M. Methylphenidate as needed for fatigue in patients with advanced cancer. A prospective, double-blind, and placebo-controlled study. J Pain Symptom Manag. 2020, 60:992-1002. 10.1016\/j.jpainsymman.2020.05.023","journal-title":"J Pain Symptom Manag"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2020-002454","article-title":"Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo","volume":"12","author":"Centeno C","year":"2022","unstructured":"Centeno C, Roj\u00ed R, Portela MA, et al.. Improved cancer-related fatigue in a randomised clinical trial: methylphenidate no better than placebo. BMJ Support Palliat Care. 2022, 12:226-34. 10.1136\/bmjspcare-2020-002454","journal-title":"BMJ Support Palliat Care"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1089\/cap.2010.0030","article-title":"Methylphenidate treatment and dyskinesia in children with attention-deficit\/hyperactivity disorder","volume":"21","author":"Bal\u00e1zs J","year":"2011","unstructured":"Bal\u00e1zs J, Dallos G, Kereszt\u00e9ny A, Czobor P, G\u00e1doros J. Methylphenidate treatment and dyskinesia in children with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2011, 21:133-8. 10.1089\/cap.2010.0030","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1087054716679262","article-title":"Dyskinesia in treatment-naive and stimulant-treated children with ADHD","volume":"24","author":"Kereszt\u00e9ny \u00c1","year":"2020","unstructured":"Kereszt\u00e9ny \u00c1, Ferenczi-Dallos G, Vel\u0151 S, G\u00e1doros J, Bal\u00e1zs J. Dyskinesia in treatment-naive and stimulant-treated children with ADHD. J Atten Disord. 2020, 24:981-9. 10.1177\/1087054716679262","journal-title":"J Atten Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2014.03.021","article-title":"Adult onset methylphenidate induced dyskinesia after stroke","volume":"20","author":"Kim JY","year":"2014","unstructured":"Kim JY, Baik JS. Adult onset methylphenidate induced dyskinesia after stroke. Parkinsonism Relat Disord. 2014, 20:789-91. 10.1016\/j.parkreldis.2014.03.021","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/340667-methylphenidate-induced-dyskinesia-in-a-47-year-old-female-with-acute-lymphoblastic-leukemia","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T13:11:18Z","timestamp":1739538678000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/340667-methylphenidate-induced-dyskinesia-in-a-47-year-old-female-with-acute-lymphoblastic-leukemia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,14]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.78995","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2,14]]}}}